glp 1 shortage tracker Ro launches GLP-1 supply to help patients navigate shortages Wegovy, Zepbound Shortages Cause Ro

However, if any severe symptoms are experienced, such as significant upper abdominal pain with nausea and vomiting, we recommend urgent evaluation given the possibility of pancreatitis or other more acute conditions

Stomach paralysis, medically known as gastroparesis, is a condition in which the stomach muscles no longer move food through the digestive tract at a normal rate

Individuals receiving the medications through self-pay or other non-plan distribution channels were not included in this analysis

Competitive Landscape Some of the major key players in the GLP-1 agonists market are: Approved GLP-1 Producers o Novo Nordisk A/S o Eli Lilly and Company o Sanofi S.A

Eli Lilly held approximately 57% of the market as of early 2025, with Novo Nordisk trailing slightly behind as it grapples with supply constraints

Hair loss, while its more cosmetic, can be devastating